Handelsbanken Fonder AB Buys New Position in American Healthcare REIT, Inc. (NYSE:AHR)

Handelsbanken Fonder AB bought a new stake in shares of American Healthcare REIT, Inc. (NYSE:AHRFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 38,800 shares of the company’s stock, valued at approximately $1,103,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wilmington Savings Fund Society FSB bought a new stake in shares of American Healthcare REIT during the 3rd quarter valued at about $28,000. GAMMA Investing LLC raised its stake in American Healthcare REIT by 104.1% during the 4th quarter. GAMMA Investing LLC now owns 988 shares of the company’s stock worth $28,000 after buying an additional 504 shares during the period. Carolina Wealth Advisors LLC acquired a new position in American Healthcare REIT during the 4th quarter worth approximately $29,000. Quarry LP acquired a new position in American Healthcare REIT during the 3rd quarter worth approximately $33,000. Finally, Decker Retirement Planning Inc. acquired a new position in American Healthcare REIT during the 4th quarter worth approximately $37,000. Institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Performance

Shares of AHR opened at $30.08 on Friday. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $4.60 billion and a price-to-earnings ratio of -62.66. The stock has a 50 day moving average of $28.27 and a 200 day moving average of $26.15. American Healthcare REIT, Inc. has a 12 month low of $12.81 and a 12 month high of $30.34.

American Healthcare REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.32%. The ex-dividend date was Tuesday, December 31st. American Healthcare REIT’s payout ratio is -208.33%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Royal Bank of Canada upped their price target on American Healthcare REIT from $28.00 to $30.00 and gave the stock an “outperform” rating in a research note on Monday, November 18th. Morgan Stanley upped their price target on American Healthcare REIT from $27.00 to $29.00 and gave the stock an “overweight” rating in a research note on Monday, December 30th. Finally, Truist Financial upped their price target on American Healthcare REIT from $27.00 to $29.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $26.00.

Read Our Latest Report on AHR

American Healthcare REIT Company Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Further Reading

Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHRFree Report).

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.